Hashiguchi Y, Muro K, Saito Y, Ito Y et al (2020) Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol 25(1):1–42. https://doi.org/10.1007/s10147-019-01485-z
Kobayashi H, Mochizuki H, Kato T et al (2009) Outcomes of surgery alone for lower rectal cancer with and without pelvic sidewall dissection. Dis Colon Rectum 52(4):567–576. https://doi.org/10.1007/DCR.0b013e3181a1d994
Fujita S, Mizusawa J, Kanemitsu Y et al (2017) Mesorectal excision with or without lateral lymph node dissection for clinical Stage II/III lower rectal cancer (JCOG0212): a multicenter, randomized controlled, noninferiority trial. Ann Surg 266(2):201–207. https://doi.org/10.1097/SLA.0000000000002212
Glynne-Jones R, Wyrwicz L, Tiret E et al (2018) Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 29(Suppl 4):263. https://doi.org/10.1093/annonc/mdy161
Tsukada Y, Rullier E, Shiraishi T et al (2023) Comparison between preoperative chemoradiotherapy and lateral pelvic lymph node dissection in clinical T3 low rectal cancer without enlarged lateral lymph nodes. Colorectal Dis 25(6):1153–1162. https://doi.org/10.1111/codi.16535
Ogura A, Konishi T, Cunningham C et al (2019) Neoadjuvant (chemo)radiotherapy with total mesorectal excision only is not sufficient to prevent lateral local recurrence in enlarged nodes: results of the multicenter lateral node study of patients with low cT3/4 rectal cancer. J Clin Oncol 37(1):33–43. https://doi.org/10.1200/JCO.18.00032
Ogura A, Konishi T, Beets GL et al (2019) Lateral nodal features on restaging magnetic resonance imaging associated with lateral local recurrence in low rectal cancer after neoadjuvant chemoradiotherapy or radiotherapy. JAMA Surg 154(9):e192172. https://doi.org/10.1001/jamasurg.2019.2172
Article PubMed PubMed Central Google Scholar
Harris CA, Solomon MJ, Heriot AG et al (2016) The outcomes and patterns of treatment failure after surgery for locally recurrent rectal cancer. Ann Surg 264(2):323–329. https://doi.org/10.1097/SLA.0000000000001524
Song SH, Choi GS, Kim HJ et al (2021) Long-term clinical outcomes of total mesorectal excision and selective lateral pelvic lymph node dissection for advanced low rectal cancer: a comparative study of a robotic versus laparoscopic approach. Tech Coloproctol 25(4):413–423. https://doi.org/10.1007/s10151-020-02383-7
Du R, Zhou J, Li D et al (2021) Postoperative morbidity and mortality after mesorectal excision with laparoscopic versus conventional open lateral lymph node dissection for advanced rectal cancer: a meta-analysis. Asian J Surg 44(1):26–35. https://doi.org/10.1016/j.asjsur.2020.06.010
Yamaguchi T, Kinugasa Y, Shiomi A et al (2018) Oncological outcomes of robotic-assisted laparoscopic versus open lateral lymph node dissection for locally advanced low rectal cancer. Surg Endosc 32(11):4498–4505. https://doi.org/10.1007/s00464-018-6197-x
Sylla P, Rattner DW, Delgado S, Lacy AM (2010) NOTES transanal rectal cancer resection using transanal endoscopic microsurgery and laparoscopic assistance. Surg Endosc 24(5):1205–1210. https://doi.org/10.1007/s00464-010-0965-6
Persiani R, Biondi A, Pennestrì F et al (2018) Transanal total mesorectal excision vs laparoscopic total mesorectal excision in the treatment of low and middle rectal cancer: a propensity score matching analysis. Dis Colon Rectum 61(7):809–816. https://doi.org/10.1097/DCR.0000000000001063
Penna M, Hompes R, Arnold S et al (2017) Transanal total mesorectal excision: international registry results of the first 720 cases. Ann Surg 266(1):111–117. https://doi.org/10.1097/SLA.0000000000001948
Perdawood SK, Al Khefagie GA (2016) Transanal vs laparoscopic total mesorectal excision for rectal cancer: initial experience from Denmark. Colorectal Dis 18(1):51–58. https://doi.org/10.1111/codi.13225
Adachi T, Kitaguchi D, Teramura K et al (2023) Single-center comparative study of short-term outcomes of transanal and laparoscopic total mesorectal excisions for low and middle rectal cancers. Surg Endosc 37(6):4698–4706. https://doi.org/10.1007/s00464-023-09948-1
Serra-Aracil X, Zarate A, Bargalló J et al (2023) Transanal versus laparoscopic total mesorectal excision for mid and low rectal cancer (Ta-LaTME study): multicentre, randomized, open-label trial. Br J Surg 110(2):150–158. https://doi.org/10.1093/bjs/znac324
Liu H, Zeng Z, Zhang H et al (2023) Morbidity, mortality, and pathologic outcomes of transanal versus laparoscopic total mesorectal excision for rectal cancer short-term outcomes from a multicenter randomized controlled trial. Ann Surg 277(1):1–6. https://doi.org/10.1097/SLA.0000000000005523
Rutgers ML, Burghgraef TA, Hol JC et al (2024) Total mesorectal excision in MRI-defined low rectal cancer: multicentre study comparing oncological outcomes of robotic, laparoscopic and transanal total mesorectal excision in high-volume centres. BJS Open. https://doi.org/10.1093/bjsopen/zrae029
Article PubMed PubMed Central Google Scholar
Ye J, Tian Y, Li F et al (2021) Comparison of transanal total mesorectal excision (TaTME) versus laparoscopic TME for rectal cancer: a case matched study. Eur J Surg Oncol 47(5):1019–1025. https://doi.org/10.1016/j.ejso.2020.11.131
Matsuda T, Takemasa I, Endo H et al (2024) Local recurrence of rectal cancer after transanal total mesorectal excision and risk factors: a nationwide multicenter cohort study in Japan. Ann Surg Open 5(1):e369. https://doi.org/10.1097/AS9.0000000000000369
Article PubMed PubMed Central Google Scholar
Neary E, Ibrahim T, Verschoor CP et al (2024) A systematic review and meta-analysis of oncological outcomes with transanal total mesorectal excision for rectal cancer. Colorectal Dis 26(5):837–850. https://doi.org/10.1111/codi.16982
Suzuki Y, Hasegawa H, Mori T et al (2024) Cytological analysis of the surgical field during transanal total mesorectal excision for rectal cancer: a prospective study. Dis Colon Rectum 67(8):1009–1017. https://doi.org/10.1097/DCR.0000000000003300
Zewde MG, Peyser DK, Yu AT et al (2024) Oncologic outcomes following transanal total mesorectal excision: the United States experience. Surg Endosc 38(7):3703–3715. https://doi.org/10.1007/s00464-024-10896-7
Narihiro S, Kitaguchi D, Ikeda K et al (2023) Two-team lateral lymph node dissection assisted by the transanal approach for locally advanced lower rectal cancer: comparison with the conventional transabdominal approach. Surg Endosc 37(7):5256–5264. https://doi.org/10.1007/s00464-023-10012-1
Matsuda T, Yamashita K, Hasegawa H et al (2021) Two-team lateral pelvic lymph node dissection assisted by the transanal approach. Dis Colon Rectum 64(12):e719–e724. https://doi.org/10.1097/DCR.0000000000002143
Watanabe J, Ishibe A, Suwa Y et al (2020) Autonomic nerve-preserving lymph node dissection for lateral pelvic lymph node metastasis of the pelvic floor using the transanal approach. Dis Colon Rectum 63(1):113–114. https://doi.org/10.1097/DCR.0000000000001478
Yamaguchi T, Kinugasa Y, Shiomi A, Tomioka H, Kagawa H (2016) Robotic-assisted laparoscopic versus open lateral lymph node dissection for advanced lower rectal cancer. Surg Endosc 30(2):721–728. https://doi.org/10.1007/s00464-015-4266-y
Oshio H, Oshima Y, Yunome G et al (2022) Potential urinary function benefits of initial robotic surgery for rectal cancer in the introductory phase. J Robot Surg 16(1):159–168. https://doi.org/10.1007/s11701-021-01216-5
Kim HJ, Choi GS, Park JS, Park SY, Yang CS, Lee HJ (2018) The impact of robotic surgery on quality of life, urinary and sexual function following total mesorectal excision for rectal cancer: a propensity score-matched analysis with laparoscopic surgery. Colorectal Dis 20(5):O103–O113-o13. https://doi.org/10.1111/codi.14051
Kanao H, Fu
留言 (0)